0941-0707 NDC - EXTRANEAL ()

Drug Information

  • Product NDC: 0941-0707
  • Proprietary Name: EXTRANEAL
  • Non Proprietary Name:
  • Active Ingredient(s): 25.7 mg/100mL CALCIUM CHLORIDE; 7.5 g/100mL ICODEXTRIN; 5.08 mg/100mL MAGNESIUM CHLORIDE; 538 mg/100mL SODIUM CHLORIDE; 448 mg/100mL SODIUM LACTATE
  • Administration Route(s):
  • Dosage Form(s):
  • Pharmacy Class(es): Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Field Name Field Value
Labeler Name: Vantive US Healthcare LLC
Product Type:
FDA Application Number:
Marketing Category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Start Marketing Date:12/11/2024
End Marketing Date:5/13/2025

Package Information

No. Package Code Package Description Billing Unit
10941-0707-066 BAG in 1 CARTON (0941-0707-06) / 2000 mL in 1 BAG (0941-0707-01)
20941-0707-086 BAG in 1 CARTON (0941-0707-08) / 2000 mL in 1 BAG (0941-0707-03)

NDC Record

Field Name Field Value Definition
PRODUCT NDC0941-0707The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEEXTRANEALThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE12/11/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE5/13/2025This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED DRUG FOR USE IN DRUG SHORTAGEProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEVantive US Healthcare LLCName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC0941-0707The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEEXTRANEALThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE10/23/2024This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE2/12/2027This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED DRUG FOR USE IN DRUG SHORTAGEProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEVantive US Healthcare LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code